Webinar: Gain fast-track market access to the rapidly growing Chinese healthcare market
How can your company enter the rapidly growing Chinese healthcare market and how can you benefit from the particular rules, incentives and opportunities of the Hainan Boao Lecheng International Medical Tourism Pilot Zone (Hainan Boao Lecheng) as an entry point to the rest of China? Learn more in this webinar and ask questions to the China-experts.
With a global share of 20%, the Chinese medical device market is the world’s second largest with an estimated value of 800 billion RMB (~115 billion USD) in 2020 and annual growth rates of 20% since 2015.
To meet the growing demand for high-quality healthcare, China is investing heavily in medical F&U, IT, AI, modern hospitals, new medical devices, medicine, and treatments.
In this regard, Hainan Boao Lecheng has been designated as a special medical zone in China, receiving special incentives in September 2019 to create an international medical destination and world-class cluster for advanced medical care, professional rehabilitation, medical R&D and technological innovation in China.
What do you gain from attending this webinar?
- Get a quick overview of the Chinese healthcare market
- Get introduced to Hainan Boao Lecheng International Medical Zone
- Learn about the opportunities and challenges of the Chinese market
- Get introduced to the ‘NLSP step-by-step market entry model’
- Get to know what you as a company can expect
- Ask questions to the experts
The webinar is held in English.
Who can participate?
Companies with a CE mark or FDA approval who are interested in the Chinese market and seek practical advice and services from experienced China experts.
Program
- Welcome and introduction
- Overview of the Chinese healthcare market
- Introduction to Hainan Boao Lecheng International Medical Zone
- Opportunities and challenges in the Chinese market
- NLSP step-by-step market entry model
- Alignment of expectations with companies
- Q&A
NB! When you sign up, you must choose whether you want to participate online or physically (max 30 people).
Facts about Hainan Boao Lecheng
Hainan Boao Lecheng offers fast-track approval procedures that make it easier and faster to register, import and sell medical devices for use in Hainan Boao Lecheng, which are not yet registered in China, but approved abroad with a CE mark or FDA license.
It is also the only place in China today where Real-World Data can be collected and used from the use of medical devices imported under the rapid approval procedures, which can supplement the application for the national NMPA registration, which can speed up the approval process for sales in the rest of China.
About the partners behind the webinar
To give Danish companies within medtech, healthtech and rehabilitation safe, efficient and easier access to the Chinese health market, Danish Life Science Cluster, The Trade Council i China and the Innovation Centre Denmark in Shanghai have established a partnership with Nordic Life Science Platform ApS, who collaborates with Hainan Boao Lecheng and offers step-by-step market access with advice and associated services.
The partnership is unique in its form of cooperation, as the focus is on performing direct commercial match-making for Danish companies by identifying specific needs and wishes of the Chinese hospitals in Hainan Boao Lecheng and matching them with specific products and solutions from Denmark.
In addition, the Partnership follows the participating companies from the start of the journey towards a possible NMPA approval for commercialization in the rest of China.